The difficulties in diagnosing Alzheimer's disease and Down's syndrome Dr Marwan Sabbagh
Dr. Marwan Sabbagh On AAIC 2024: It's "Heads Down. Now, Let's Get to Work" It's been 15 years since a new drug has been approved for Alzheimer's. In that time, 8 billion has been invested in drug In this interview, Dr. Marwan Sabbagh sits down with NeuroReserve's Marketing Director, Maureen Marsic, to talk about his ...